Leaflet CEFUROXIMA ATB 750mg powder for suspension for intramuscular injection / solution for intramuscular / intravenoUS INJECTION


Indicated for: bacterial infections

Substance: cefuroxime (cephalosporin antibiotic)

ATC: J01DC02 (Antiinfectives for systemic use | Other beta-lactam antibacterials | Second-generation cephalosporins)

Cefuroxime is a second-generation cephalosporin antibiotic used to treat moderate bacterial infections. It is indicated for upper respiratory tract infections (such as sinusitis, tonsillitis, or pharyngitis), lower respiratory tract infections (bronchitis, pneumonia), urinary tract infections, otitis media, skin and soft tissue infections, as well as some bone and joint infections.

Cefuroxime works by inhibiting bacterial cell wall synthesis, killing the bacteria responsible for the infection. It is available in tablet, oral suspension, or injectable solution form.

Side effects may include nausea, diarrhea, abdominal pain, skin rashes, or allergic reactions. In rare cases, it can cause pseudomembranous colitis or severe hypersensitivity reactions. It is contraindicated in patients with allergies to cephalosporins or penicillins.

General data about CEFUROXIMA ATB 750mg

  • Substance: cefuroxime
  • Date of last drug list: 01-05-2026
  • Commercial code: W51943006
  • Concentration: 750mg
  • Pharmaceutical form: powder for suspension for intramuscular injection / solution for intramuscular / intraveno
  • Quantity: 10
  • Product type: generic
  • Price: 94.05 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ANTIBIOTICE S.A. - ROMANIA
  • Holder: ANTIBIOTICE S.A. - ROMANIA
  • Number: 7294/2015/06
  • Shelf life: 2 years

Concentrations available for cefuroxime

  • 1.5g
  • 125mg
  • 125mg/5ml
  • 1500mg
  • 250mg
  • 250mg/5ml
  • 500mg
  • 50mg
  • 750mg